2016
DOI: 10.1161/hypertensionaha.116.07250
|View full text |Cite
|
Sign up to set email alerts
|

Selective Heart Rate Reduction With Ivabradine Increases Central Blood Pressure in Stable Coronary Artery Disease

Abstract: Heart rate (HR) lowering by β-blockade was shown to be beneficial after myocardial infarction. In contrast, HR lowering with ivabradine was found to confer no benefits in 2 prospective randomized trials in patients with coronary artery disease. We hypothesized that this inefficacy could be in part related to ivabradine's effect on central (aortic) pressure. Our study included 46 patients with chronic stable coronary artery disease who were randomly allocated to placebo (n=23) or ivabradine (n=23) in a single-b… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
21
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 36 publications
(24 citation statements)
references
References 31 publications
3
21
0
Order By: Relevance
“…A high value of SV due to the prolonged LV (left ventricle) filling time increases LV preload and higher values of systemic PP and central systolic pressure increase LV afterload. This indicates that lowering HR should be considered cautiously in patients, which supports previous conclusion (Rimoldi et al, 2016 ).…”
Section: Discussionsupporting
confidence: 90%
See 2 more Smart Citations
“…A high value of SV due to the prolonged LV (left ventricle) filling time increases LV preload and higher values of systemic PP and central systolic pressure increase LV afterload. This indicates that lowering HR should be considered cautiously in patients, which supports previous conclusion (Rimoldi et al, 2016 ).…”
Section: Discussionsupporting
confidence: 90%
“…It has been documented that pharmacological HR lowering in patients with high BP can result in adverse cardiovascular outcomes (Rimoldi et al, 2016 ). Here, we showed significantly higher values of SV, systemic PP, and central systolic pressure at baseline as compared to HR of 135 and 155 bpm in swine.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…On the other hand, bisoprolol may be useful in hypertensive patients with cardiac or vascular diseases who have advanced atherosclerotic changes and sympathetic nervous system activation. Recently, the decrease in PR with ivabradine was associated with an increase in central SBP in patients with coronary artery disease 14) . However, in our study, such an effect was not observed in the hypertensive subjects, and the treatments did not cause a cardiovascular overload.…”
Section: )mentioning
confidence: 99%
“…The duration of the cardiac cycle determines the length of diastole and influences the shape of the arterial pressure waveform (Wilkinson et al, 2000 ; Lantelme et al, 2002 ; Albaladejo et al, 2004 ; Haesler et al, 2004 ; Westerhof et al, 2008 ; Mackenzie et al, 2009 ; Benetos et al, 2010 ; Westerhof and Westerhof, 2013 ; Rimoldi et al, 2016 ). Recently, studies in both animals and humans using pacing or a selective negative chronotropic agent alleged evidence for an inverse relationship between PP and heart rate (HR) (Lantelme et al, 2002 ; Albaladejo et al, 2004 ; Haesler et al, 2004 ; Rimoldi et al, 2016 ). A lower HR prolongates diastole more than systole, widening PP (Figure 1 ; Folkow and Ely, 1998 ).…”
Section: Introductionmentioning
confidence: 99%